As the mainstay treatment for advanced prostate cance action of androgen receptor (AR) by reducing androgen le androgens for binding to AR. Albeit effective in extendi toxicity and the development of castration-resistant pro CRPC is lethal and incurable, developing effective strateg resistance becomes an urgent task. Continuous AR signali development of CRPC. The present study showed that m reduces AR abundance, could enhance the cancer-killi at the and a ase. T f the ifican i-and role
Reactivated androgen receptor (AR) signaling drives castration-resistant prostate cancer (CRPC). Nov...
Persistent androgen receptor (AR) signaling in castration resistant prostate cancer (CRPC) underpins...
It is now well established that hormonal pathways are involved in the development of prostate cancer...
Resistance to androgen deprivation therapies and increased androgen receptor (AR) activity are major...
Telomere stability is important for cell viability, as cells with telomere DNA damage that is not re...
Prostate cancer is the second leading cause of death from cancer among males in Western countries. I...
Contains fulltext : 172475.pdf (publisher's version ) (Open Access)Significant pro...
The androgen receptor (AR) is a key regulator for the growth, differentiation and survival of prosta...
Recurrent, metastatic prostate cancer continues to be a leading cause of cancer-death in men. The a...
Telomere stability is important for cell viability, as cells with telomere DNA damage that is not re...
Targeted gene therapy is a promising approach for treating prostate cancer after the discovery of pr...
Every year 223,000 men will be diagnosed with prostate cancer in the United States with most patient...
Men who develop metastatic castration-resistant prostate cancer (CRPC) invariably succumb to the dis...
Purpose: Progression to the castration-resistant state is the incurable and lethal end stage of pros...
Androgen deprivation therapies (ADTs) are important treatments which inhibit androgen-induced prosta...
Reactivated androgen receptor (AR) signaling drives castration-resistant prostate cancer (CRPC). Nov...
Persistent androgen receptor (AR) signaling in castration resistant prostate cancer (CRPC) underpins...
It is now well established that hormonal pathways are involved in the development of prostate cancer...
Resistance to androgen deprivation therapies and increased androgen receptor (AR) activity are major...
Telomere stability is important for cell viability, as cells with telomere DNA damage that is not re...
Prostate cancer is the second leading cause of death from cancer among males in Western countries. I...
Contains fulltext : 172475.pdf (publisher's version ) (Open Access)Significant pro...
The androgen receptor (AR) is a key regulator for the growth, differentiation and survival of prosta...
Recurrent, metastatic prostate cancer continues to be a leading cause of cancer-death in men. The a...
Telomere stability is important for cell viability, as cells with telomere DNA damage that is not re...
Targeted gene therapy is a promising approach for treating prostate cancer after the discovery of pr...
Every year 223,000 men will be diagnosed with prostate cancer in the United States with most patient...
Men who develop metastatic castration-resistant prostate cancer (CRPC) invariably succumb to the dis...
Purpose: Progression to the castration-resistant state is the incurable and lethal end stage of pros...
Androgen deprivation therapies (ADTs) are important treatments which inhibit androgen-induced prosta...
Reactivated androgen receptor (AR) signaling drives castration-resistant prostate cancer (CRPC). Nov...
Persistent androgen receptor (AR) signaling in castration resistant prostate cancer (CRPC) underpins...
It is now well established that hormonal pathways are involved in the development of prostate cancer...